Tom Harkin

Ask Your Senators to Support the Accelerating Biomedical Research Act Funding to the National Institutes of Health (NIH) has remained flat in recent years, and uncertainty is growing over the ability of universities and other research institutions to conduct the noncommercial medical research underlying new preventative measures, diagnostic tools, treatments, and cures. In response to significant concerns about the erosion of NIH’€™s purchasing power, Senator Tom Harkin (D-IA) has introduced legislation, the Advancing Biomedical Research Act, that empowers Congress to provide up to 10% increases in NIH funding for FY 2015 and FY 2016, and up to 5% increases through 2021. These increases are...
Dear Research Advocate: Today, Senator Tom Harkin (D-IA) ’€” one of the most effective and dedicated champions of medical and health research ever to serve in public office ’€” introduced major new legislation, the Accelerate Biomedical Research Act. This visionary legislation would increase the budget caps in order to boost National Institutes of Health (NIH) funding to $46.2 billion by FY 2021, a strategy for restoring NIH purchasing power without cutting into funding for other national priorities. You can view my statement on the legislation here and our thank you letter to the Senator here . It would be terrific if you would write a letter of support for the legislation and send a...
Research!America applauds Senator Tom Harkin for taking bold, decisive action to heal fissures in our nation’€™s research pipeline with legislation that will strengthen the National Institutes of Health (NIH) budget over the next six years. The Accelerate Biomedical Research Act will establish a pathway for sustained growth in the NIH budget. That budget has remained virtually stagnant over the last decade, jeopardizing promising research to combat disease and deflating the aspirations of early career scientists. NIH-funded research fuels the development of lifesaving therapies and treatments, and creates opportunities for public-private partnerships to better understand Alzheimer’€™s,...
Dear Research Advocate: The doubling of the National Institutes of Health budget between FY99 and FY03 is an example of Congress at its most productive ’€¦ and it hinged on bipartisanship. A small group of Republicans and Democrats recognized the power of medical progress, and they worked together to increase the budget baseline for NIH by nearly $11.5 billion. Without that doubling, and with the stagnation of virtually all non-defense discretionary funding that followed on its heels, which groundbreaking medical discoveries would still lie dormant? Which of those we hold dear would not be alive today? Research!America Chair and former Congressman John Porter, who chaired the House Labor-...
Dear Research Advocate: This week the Senate Appropriations Committee voted to increase NIH funding by $307 million in FY14, an increase largely due to the unwavering support of Labor-HHS subcommittee Chair Tom Harkin and Appropriations Committee Chair Barbara Mikulski. The Senate bill also increases funding for the CDC by $1.6 billion over FY13. It is important to note that the Senate bill does not include sequestration reductions, but Mikulski has vowed to fight these dangerous, continued cuts. (See my brief statement on this week’€™s Senate action.) We all realize that these proposed funding levels are not adequate to capitalize on the current opportunity in science and respond robustly...
Dear Research Advocate: This week the Senate Appropriations Committee voted to increase NIH funding by $307 million in FY14, an increase largely due to the unwavering support of Labor-HHS subcommittee Chair Tom Harkin and Appropriations Committee Chair Barbara Mikulski. The Senate bill also increases funding for the CDC by $1.6 billion over FY13. It is important to note that the Senate bill does not include sequestration reductions, but Mikulski has vowed to fight these dangerous, continued cuts. (See my brief statement on this week’€™s Senate action.) We all realize that these proposed funding levels are not adequate to capitalize on the current opportunity in science and respond robustly...
July 9, 2013 The Senate subcommittee markup of the Labor-Health and Human Services-Education FY14 spending bill goes a step in the right direction in softening the blow sequestration has dealt to the hopes and expectations of patients and their families. Sequestration’€™s across-the-board spending cuts have sent no-confidence signals across the full ecosystem of medical research and innovation in the public and private sector. There’€™s a reason that, according to a recent national public opinion poll commissioned by Research!America, nearly half of Americans (48%) do not believe we are making enough progress in medical research in the U.S. This nation can’€™t push ahead forcefully with one...
Dear Research Advocate, Glimmers of hope can be found in the dire funding situation we face under sequestration. The continuing resolution (C.R.) funding the government through the end of the fiscal year (September 30) included very small increases for NIH, CDC, NSF and FDA; AHRQ was flat funded. But the fact remains that these increases were overwhelmed by the effect of sequestration, which remains in place and will continue to weigh us down for 10 years unless overturned. Our champions in Congress are speaking out and taking a stand on behalf of research as the budget negotiation proceeds. Reps. McKinley (R-WV) and Markey (D-MA) have co-authored a letter to House appropriators calling for...
Dear Research Advocate, Today, the Senate is planning to vote on a bipartisan continuing resolution from Sens. Mikulski and Shelby to fund the federal government through the end of the year. The good news is that the bill includes an increase, albeit small ($71 million) in NIH funding; Senator Harkin tried, unsuccessfully, unfortunately, to increase NIH even further, and Senator Durbin worked on an ambitious amendment to add more than $1.5 billion to the NIH budget. We truly appreciate the efforts of all of these champions and the fact that NIH funding was singled out for an increase on a bipartisan basis by the Appropriations Committee. The bad news is that sequestration will wipe out all...
Sen. Tom Harkin (D-IA), left, and Sen. Frank Lautenberg (D-NJ) both spoke at the American Cancer Society Cancer Action Network rally on Capitol Hill on Thursday. Behind them is Christopher Hansen, president of ACS-CAN. The American Cancer Society and its advocacy arm, the American Cancer Society Cancer Action Network, kicked off its lobby day on Capitol Hill with a rally that urged Congress to preserve funding for research, prevention and treatment of cancer. But the event wasn’t just about cancer: Four Division I men’s basketball coaches also helped kick off the rally. But it wasn’t merely a token appearance. The coaches ’€” Tad Boyle of the University of Colorado, Paul Hewitt of George...

Pages

Sidebar Quote

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter